There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Abstract
Patients with genotype 1 hepatitis C virus (HCV) who do not have a sustained response
to therapy with peginterferon alfa and ribavirin have a low likelihood of success
with retreatment.